Andrew J. Cutler - 31 Jul 2026 Form 4 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Reporting relationship: Director
Issuer ticker: JUNS
Reported as of: 31 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2026, 16:05:16 UTC
Prior SEC filing: 22 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew J Cutler

Key filing fact

Andrew J. Cutler filed Form 4 for JUPITER NEUROSCIENCES, INC. (JUNS) on 05 Aug 2026.

Key facts

This page summarizes Andrew J. Cutler's Form 4 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2026, 16:05.

Change

Previous filing in this sequence was filed on 22 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002144263 Primary reporting owner

Cutler Andrew Jon

Relationship: Director
Address: C/O JUPITER NEUROSCIENCES, INC., 11621 KEW GARDENS DRIVE, SUITE 210, PALM BEACH GARDENS
Signature: /s/ Andrew J Cutler
Signature date: 05 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JUNS transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +472,222
Change %
Price: $0.000000^*
Shares after: 472,222
Date: 31 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 472,222
Exercise price: $0.0900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of 472,222 stock options (each representing the right to purchase one share of Common Stock) under the Issuer's 2025 Equity Incentive Plan. The options were granted in connection with the Reporting Person's appointment to the Board of Directors and the options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. The options vest with 25 % upfront and the remaining vest in 3 quarterly installments beginning February 1, 2026, subject to the Reporting Person's continued service as a director through each vesting date.